AbbVie Inc. (NYSE:ABBV) has declared another quarterly dividend of $1.73 per share. The dividend will be paid on November 16, ...

It is certainly a good Dividend King to buy in September.

These three stocks meet multiple criteria for long-term dividend investing success.

Citadel, Ken Griffin's hedge fund, materially increased its stake in AbbVie; here's why you may want to follow that lead.

Pfizer's 6% dividend yield is enticing, but AbbVie's dividend growth is superior.

AbbVie's dividend is a very appealing factor.

Johnson & Johnson is one of the more diversified healthcare stocks on the market. The company's business spans pharmaceuticals and medical devices. Within both niches, Johnson & Johnson operates ...

NORTH CHICAGO, Ill., June 18, 2026 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.73 per share. The cash dividend is payable August ...

The first half of 2026 saw market volatility with geopolitical friction. However, the S&P 500 recovered, fueled by AI earnings. Goldman Sachs projects an S&P 500 target of 8,000. However, risks ...

Pfizer's 6.4% yield and cheap valuation support a $35 target; Chevron's Hess synergies and Microsoft power deal back $250 by 2027. AbbVie's Skyrizi and Rinvoq each grew over 20% in Q2, driving ...

I last covered AbbVie Inc. (ABBV)(ABBV:CA) on Feb 26 with an article titled “Health Care Q4 Dividend Roundup: Merck Offers Thicker Dividend Cushion Than AbbVie”. The article served as a review of ABBV ...